How many FDA warning letters has MANKIND PHARMA received?

Argus HQ has not recorded an FDA warning letter for MANKIND PHARMA in our current dataset.

What FDA recalls has MANKIND PHARMA issued?

Argus HQ has not recorded an FDA recall tied to MANKIND PHARMA in our current dataset.

Is MANKIND PHARMA FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for MANKIND PHARMA. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

MANKIND PHARMA

Name: FDA Enforcement Actions Against MANKIND PHARMA
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-07-01
MANKIND PHARMA — ANDA approval: RIVAROXABAN (unspecified)

Frequently asked questions

How many FDA warning letters has MANKIND PHARMA received?: Argus HQ has not recorded an FDA warning letter for MANKIND PHARMA in our current dataset.
What FDA recalls has MANKIND PHARMA issued?: Argus HQ has not recorded an FDA recall tied to MANKIND PHARMA in our current dataset.
Is MANKIND PHARMA FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for MANKIND PHARMA. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.